BeOne Medicines (ONC) Cash & Equivalents Growth (3y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -51.77% |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | 24.73% |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 4.69% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | 13.33% |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | -16.07% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -8.88% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 21.66% |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 36.53% |
| 10 | BeOne Medicines | - | - | 1.35 Bn | 10.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.63% |
| Dec 31, 2025 | 5.53% |
| Sep 30, 2025 | 2,664.84% |
| Jun 30, 2025 | -15.27% |
| Mar 31, 2025 | 1,868.29% |
| Dec 31, 2024 | 1,900.87% |
| Sep 30, 2024 | 25.00% |
| Jun 30, 2024 | 13.43% |
| Mar 31, 2024 | 1,992.23% |
| Dec 31, 2023 | 31.91% |
| Sep 30, 2023 | 27.95% |
| Jun 30, 2023 | 2,192.65% |
| Mar 31, 2023 | 2,223.78% |
| Dec 31, 2022 | 84.31% |
| Sep 30, 2022 | -76.26% |
| Jun 30, 2022 | 577.56% |
| Mar 31, 2022 | -71.92% |
| Dec 31, 2021 | -71.75% |
| Sep 30, 2021 | 356.30% |
| Jun 30, 2021 | 59.42% |
| Mar 31, 2021 | -74.05% |
| Dec 31, 2020 | 79.34% |
| Sep 30, 2020 | 91.51% |
| Jun 30, 2020 | -89.73% |
| Mar 31, 2020 | -85.76% |
| Dec 31, 2019 | 91.85% |
| Sep 30, 2019 | -44.95% |
| Jun 30, 2019 | -36.94% |
| Mar 31, 2019 | -58.50% |
| Dec 31, 2018 | -6.63% |
| Sep 30, 2018 | -19.05% |
| Jun 30, 2018 | 159.27% |
| Mar 31, 2018 | 9.31% |